On Dec. 8, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration had granted Emergency Use…
On Dec. 8, 2022, the National Institutes of Health researchers reported that areas of the genome related to…
On Dec. 7, 2022, Novavax announced that Health Canada had approved a supplement to a New Drug Submission…
On Dec. 5, 2022, the Fred Hutchinson Cancer Center announced that according to a new meta-analysis women were…
On Dec. 2, 2022, the Oregon Department of Agriculture (ODA) and the U.S. Department of Agriculture’s (USDA) Animal…
On Dec. 2, 2022, in a multi-center collaboration led by Scripps Research, scientists announced they have achieved promising…
On Nov. 29, 2022, Novavax announced that the World Health Organization had issued an updated Emergency Use Listing…
On Nov. 22, 2022, the U.S. Food and Drug Administration approved the investigational gene therapy etranacogene dezaparvovec or…
On Nov. 18, 2022, Pfizer and BioNTech announced results from an analysis examining the immune response induced by…
On Nov. 18, 2022, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid (COVID-19 Vaccine (Recombinant…
On Nov. 18, 2022, the World Health Organisation for Animal Health (WHO) announced that Peru had reported its…
On Nov. 17, 2022, the U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) injection to delay the…
On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment…
On Nov. 16, 2022, resarchers at the National Institutes of Health (NIH) announced they had successfully identified differences…
On Nov. 14, 2022, Moderna announced that both of Moderna’s bivalent Omicron-targeting booster candidates (mRNA-1273.214 and mRNA-1273.222) trigger…
On Nov. 14, 2022, researchers discovered the pathway by which chronic hyperglycaemia reduces β-cell function. Their data also…
On Nov. 9, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
On Nov. 8, 2022, Novavax announced topline results from its Phase 3 Boosting Trial for the SARS-CoV-2 rS…
On Nov. 7, 2022, the NHS Blood and Transplant (NHSBT) reported that red blood cells grown in a…
On Nov. 5, 2022, the U.S. Department of Agriculture’s (USDA) Animal Plant Health Inspection Service (APHIS) confirmed the…
On Nov. 4, 2022, the Oregon Department of Agriculture (ODA) and the U.S. Department of Agriculture’s (USDA) Animal…
On Nov. 4, 2022, Moderna announced that Health Canada had authorized the use of its BA.4/BA.5 Omicron-targeting bivalent…
On Nov. 2, 2022, Hologic announced that it had been awarded a $19 million contract from the Biomedical…
On Nov. 1, 2022, the National Institutes of Health (NIH) announced that adults with hypertension saw a small,…
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
On Oct. 31, 2022, Moderna announced that it had received approval from the Ministry of Health, Labour and…
On Oct. 27, 2022, Inovio Pharma announced that it has discontinued its internally funded efforts to develop INO-4800…
On Oct. 27, 2022, the U.S. Department of Agriculture’s Animal Plant Health Inspection Service (APHIS) confirmed the presence…
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
On Oct. 26, 2022, the Barbara Ann Karmanos Cancer Institute announced it had completed an over 50,000-square-foot expansion…